Latest filingSep 02, 2026Most recent Form 4
EXOZ
EXOZYMES INC.
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$640k5 buys
Total selling$00 sells
Net open-market+$640k1 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period6transactions
- P · Open-market buys · dominant5 · 83%
- A · Grants / awards1 · 17%
Activity by reported role
A joint filing can contribute to multiple roles6transactions
- Chief executive officer · dominant6 · 100%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (1)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeHeltzen MichaelCommon Stock · Direct
14,708Aug 26, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- HM+$63.0k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
EXOZ transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| EXOZ | Heltzen Michael | CEO | grant | 8.84k | $5.65M | A | — | — | 09/02 | 08/19 |
| EXOZ | Heltzen Michael | CEO | buy | 100 | $75.0k | P | — | — | 09/02 | 08/25 |
| EXOZ | Heltzen Michael | CEO | buy | 250 | $188k | P | — | — | 09/02 | 08/25 |
| EXOZ | Heltzen Michael | CEO | buy | 250 | $190k | P | — | — | 09/02 | 08/26 |
| EXOZ | Heltzen Michael | CEO | buy | 251 | $184k | P | — | — | 09/02 | 08/26 |
| EXOZ | Heltzen Michael | CEO | buy | 4 | $3.03k | P | — | — | 09/02 | 08/26 |
EXOZYMES INC. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at EXOZYMES INC.?
Heltzen Michael.
When was the latest reported open-market purchase?
Heltzen Michael reported a buy on Aug 26, 2026 valued at $190k. Read the SEC filing.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
Net open-market buying in the selected period was $6,405.17. This describes filed transactions, not a bullish rating.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.